Thus, we demonstrated that SOCS3-GRP78-ER stress signaling was essential for the transition from cardiac hypertrophy to HF during pressure overload, and suggest that SOCS3 may represent a potential therapeutic target for treating hypertrophic heart diseases. This evidence concerns the gene SOCS3 and cardiac hypertrophy.